New drug combo after stroke shows promise in preventing early decline

NCT ID NCT07295366

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study tested whether giving a powerful cholesterol-lowering drug (evolocumab) within 6 hours after a stroke procedure (thrombectomy) could prevent early neurological worsening. 60 adults with large-vessel stroke were randomly assigned to receive either the drug plus standard care or standard care alone. The main goal was to see if the drug reduced the chance of early decline or death within a week.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE DUE TO INTRACRANIAL ATHEROSCLEROTIC LARGE VESSEL OCCLUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.